在肝癌的低氧背景下,S100A16是重塑瘤微环境的潜在目标
Dashuai Yang1, Fangrui Zhao2, Yu Zhou1
1Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, No. 99 Zhangzhidong Road, Wuchang District, Wuhan 430060, China.
International immunopharmacology
|May 11, 2024
概括
S100A16在肝癌中升高,并与低氧瘤微环境有关. 它的高表达与减少T细胞透和改变免疫细胞功能相关,影响肝癌的进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- S100蛋白家族对细胞功能至关重要,但S100A16在肝癌中的特定作用尚不清楚.
- 了解S100A16对于破译肝癌中瘤微环境的复杂性至关重要.
研究的目的:
- 为了研究S100A16在肝癌瘤微环境中的作用.
- 探索S100A16,缺氧,免疫细胞透和分化之间的关系.
主要方法:
- 对瘤组织中S100A16表达的分析及其与缺氧相关基因的相关性.
- 研究S100A16与免疫细胞透和免疫治疗反应的关联.
- 利用单细胞测序数据来研究S100A16在细胞分化和通信中的作用.
- 使用武汉队列和多重复合免疫光学验证.
主要成果:
- 在肝癌组织中,S100A16的表达显著增加,与缺氧基因相关.
- 较高的S100A16水平与T细胞透率降低和免疫细胞功能受损有关.
- 单细胞分析表明S100A16主要表达在非免疫细胞中,随着分化而增加,并与缺氧基因变异有关.
- 非免疫细胞通过S100A16介导的信号通路与免疫细胞相互作用.
结论:
- 在肝癌中,S100A16在塑造低氧瘤微环境方面发挥着重要作用.
- S100A16,缺氧和免疫细胞透之间的关联凸显了其在肝癌进展中的调节功能.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.3K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K